CLM-HT01 improved blood pressure and minimised adverse reactions in patients
Category: News
The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide
The report includes five recommendations for the government to address these issues
The projects will focus on healthcare in LMICs in the event of extreme weather
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
The platform delivers digitalised patient data to improve clinical trials and development
The chip removes cells, which could become tumours, before they are implanted in a patient
OART is increasingly emerging to assess and adapt treatment for cancer patients
The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy
The cell could be a target for new immunotherapies for the chronic disease